Five9 and IBM launch IBM Watson for Oncology in Vietnam

27-08-2018 15:25 PM
Dec 12, 2017, Five9 and IBM collaborated to organize the launching event of IBM Watson for Oncology. Five 9 announced its partnership with Phu Tho Hospital and Bao Viet Insurance company to implement IBM Watson for Oncology to help Oncologist indentify evidence-based treatment option for vietnamese cancer patients.

Deputy Minister of Health Nguyen Viet Tien is giving the opening speech 
According to the agreement between Five9 and IBM, today, Dec 12, 2017, Five9 & IBM have organized a press conference to announce the implementation of IBM Watson for Oncology – the cognitive computing system to help oncologist in Vietnam identify evidence-based cancer treatment options. For the first phase, Five9 will collaborate with Phu Tho hospitals and Bao Viet insurance company to implement IBM Watson for Oncology in Vietnam.

Watson for Oncology was developed by IBM in collaboration with Memorial Sloan Kettering Cancer Center. It can summarize key medical attributes of a patient, and provide information to oncologists to help them deliver treatment options based on training from MSK oncologists. Watson for Oncology ranks the treatment options, linking to peer-reviewed studies that have been curated by MSK. Watson for Oncology also provides a large corpus of medical evidence for a physician to consider, drawing on more than 300 medical journals, more than 200 textbooks, and nearly 15 million pages of text to provide insights about different treatment options.
IBM and MSK have been accelerating Watson for Oncology’s training and the technology is now available to assist clinicians in developing treatment plans for breast, lung, colorectal, cervical, ovarian, gastric, prostate and bladder cancers.

With more than 115,000 cancer deaths per annum, Vietnam ranks 78th in the world’s cancer map, with a fatality rate of 110 per 100,000 people. According to the latest research from Vietnam Institute for Cancer Research and Prevention, it is expected that 190,000 cancer patients will be diagnosed each year in 2020, which is 150% of the number in 2010, and more than 50% of current diagnoses take place in the third or fourth stage of cancer. In addition, annual check-ups are not common among the Vietnamese population with roughly only 22% of the population having an understanding of cancer symptoms.

Signing ceremony between Five9 and IBM
In the context of the cancer growth in Vietnam, with IBM Watson for Oncology, Five9 and Partners are hoping to establish an ecosystem in the healthcare industry in Vietnam that will bring the benefits of machine learning into clinical practice to serve the needs of doctors and patients.

“This latest collaboration with Five9 further expands IBM’s growing footprint in the adoption of Watson by well-known healthcare institutions in the Asia Pacific region,” said Eric Yeo, IBM Vietnam Country General Manager. “In communities all around the world, there is a growing need for tools that help increase efficiency and enable quick access to important information from the collective body of cancer knowledge available today. Watson for Oncology offers the promise to provide evidence-based care while enabling clinicians to spend more time focusing on their patients.”

Chairman of Five9 Vietnam Nguyen Trong Huan  
“With IBM Watson for Oncology, Vietnamese cancer patients are now having the access to one of the most advanced technologies used cancer in the world" said Chairman of Five9 Vietnam, Nguyen Trong Huan.